Since April 2019 we participate in GloPID-R, Global Research Collaboration for Infectious Disease Preparedness. This network of research funding organizations from 27 countries facilitate a rapid and effective response to infectious disease outbreaks.We also participate in the GloPID-R Data Sharing working group. We're partner of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), who also collaborates with GloPID-R.
Read the news item
How is research helping to prevent HIV and AIDS? View ongoing and completed projects.
Read more about HIV prevention
With the prospect of pathogens becoming smarter than the drug treatments we are able to develop, antimicrobial resistance is an urgent global problem. A problem that requires a multidisciplinary international approach.
Go to Antimicrobial resistanceSome of these infections can no longer be effectively treated with antibiotics, which increases the risk of dying. The One Health theme supports research into the prevention and cure of infectious disease as well as zoonoses, antimicrobial resistance, vaccination, diet and health.
Which research does ZonMw facilitate in the prevention, diagnosis and treatment of TB? View our research projects.
Read more about TB research
One of the focuses of Wageningen University & Research is Global One Health with themes that cover a broad spectrum of health and diseases in a societal context are (infectious diseases, environment, climate, society and food)
Read more about One Health at the website of Wageningen University & ResearchThe TO-REACH Consortium is pleased to share its draft Strategic Research Agenda (SRA). The SRA has the ambition to address the increasing challenges faced by health systems, directed to those research areas of major relevance in the coming years.
The update of the JPIAMR Strategic Research and Innovation Agenda on Antimicrobial Resistance (SRIA) presents an overview of recent developments and future needs for AMR research. The agenda was launched 7th May 2019.
Three projects have each been awarded 75,000 euros to implement knowledge from previous projects from the Fostering Responsible Research Practices programme.
The Lymph&Co Foundation is funding innovative scientific research from basic/preclinical research through translational research to treatment and prevention of lymphoma by outstanding researchers worldwide.
This ETH-MPH call of the MPH programme aims to:
Microplastics & Health
18 April 2019
4 June 2019,
14.00
More Knowledge with Fewer Animals
29 April 2019
2 July 2019,
23.59
ZonMw has several programmes related to this topic.
Programme Manager